$150,780,000

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

ACTION DATE2026-04-28·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50122C00028_7505_-NONE-_-NONE-

Award description

CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds CARB-X accelerator at Boston University to develop new antibacterial treatments and combat antibiotic resistance.

Sub-sectors

vaccine-developmentantibacterial-researchacademic-research

Why this matters

Addresses critical public health threat of antibiotic-resistant bacteria; strengthens U.S. biodefense and pandemic preparedness capabilities.

Supply-chain signal

Signals investment in domestic pharmaceutical R&D pipeline; may accelerate clinical-stage antibacterial candidates toward manufacturing partnerships.

U.S.–China competition angle

Positions U.S. leadership in next-generation antibiotics as China expands biotech R&D; reduces dependence on foreign pharmaceutical innovation.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002236.

Period of performance

Start

2022-06-01

End

2029-05-31

Status

activein 1110 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00028_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.